|Institutional Source||Beutler Lab|
|Gene Name||chemokine (C-C motif) receptor 3|
|Synonyms||CC-CKR3, MIP-1 alphaRL2, Cmkbr3, CKR3|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||PIT4810001 (G1)|
|Chromosomal Location||124021972-124031689 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to A at 124029608 bp|
|Amino Acid Change||Tyrosine to Asparagine at position 327 (Y327N)|
|Ref Sequence||ENSEMBL: ENSMUSP00000039107 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000039171]|
|Predicted Effect||probably benign
AA Change: Y327N
PolyPhen 2 Score 0.005 (Sensitivity: 0.97; Specificity: 0.74)
AA Change: Y327N
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a receptor for C-C type chemokines. It belongs to family 1 of the G protein-coupled receptors. This receptor binds and responds to a variety of chemokines, including eotaxin (CCL11), eotaxin-3 (CCL26), MCP-3 (CCL7), MCP-4 (CCL13), and RANTES (CCL5). It is highly expressed in eosinophils and basophils, and is also detected in TH1 and TH2 cells, as well as in airway epithelial cells. This receptor may contribute to the accumulation and activation of eosinophils and other inflammatory cells in the allergic airway. It is also known to be an entry co-receptor for HIV-1. This gene and seven other chemokine receptor genes form a chemokine receptor gene cluster on the chromosomal region 3p21. Alternatively spliced transcript variants have been described. [provided by RefSeq, Sep 2009]
PHENOTYPE: Homozygous mutation of this gene results in impaired eosinophil trafficking to the lungs and small intestine, and in increased bronchorestriction following methacholine challenge. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Ccr3||
(F):5'- TTTTGGACCCCGTACAACCTG -3'
(R):5'- TGAGCTAGAGGTCATTGTGAC -3'
(F):5'- CTGCTTTTCACAGCACATTTTTAGAG -3'
(R):5'- AGAGGTCATTGTGACTGACTTAATG -3'